AAAAAA
Results: 1-25/31
Authors:
MATTHAY KK
Citation: Kk. Matthay, STAGE 4S NEUROBLASTOMA - WHAT MAKES IT SPECIAL, Journal of clinical oncology, 16(6), 1998, pp. 2003-2006
Authors:
MATTHAY KK
PEREZ C
SEEGER RC
BRODEUR GM
SHIMADA H
ATKINSON JB
BLACK CT
GERBING R
HAASE GM
STRAM DO
SWIFT P
LUKENS JN
Citation: Kk. Matthay et al., SUCCESSFUL TREATMENT OF STAGE-III NEUROBLASTOMA BASED ON PROSPECTIVE BIOLOGIC STAGING - A CHILDRENS CANCER GROUP-STUDY, Journal of clinical oncology, 16(4), 1998, pp. 1256-1264
Authors:
MATTHAY KK
DESANTES K
HASEGAWA B
HUBERTY J
HATTNER RS
ABLIN A
REYNOLDS CP
SEEGER RC
WEINBERG VK
PRICE D
Citation: Kk. Matthay et al., PHASE-I DOSE-ESCALATION OF I-131 METAIODOBENZYLGUANIDINE WITH AUTOLOGOUS BONE-MARROW SUPPORT IN REFRACTORY NEUROBLASTOMA, Journal of clinical oncology, 16(1), 1998, pp. 229-236
Authors:
GOLDBERG SS
DESANTES K
HUBERTY JP
PRICE D
HASEGAWA BH
REYNOLDS CP
SEEGER RC
HATTNER R
MATTHAY KK
Citation: Ss. Goldberg et al., ENGRAFTMENT AFTER MYELOABLATIVE DOSES OF I-131 METAIODOBENZYLGUANIDINE FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION FOR TREATMENT OF REFRACTORY NEUROBLASTOMA, Medical and pediatric oncology, 30(6), 1998, pp. 339-346
Authors:
REYNOLDS CP
ZUO JJ
KIM NW
WANG H
LUKENS JN
MATTHAY KK
SEEGER RC
Citation: Cp. Reynolds et al., TELOMERASE EXPRESSION IN PRIMARY NEUROBLASTOMAS, European journal of cancer, 33(12), 1997, pp. 1929-1931
Authors:
CASTLEBERRY RP
PRITCHARD J
AMBROS P
BERTHOLD F
BRODEUR GM
CASTEL V
COHN SL
DEBERNARDI B
DICKSMIREAUX C
FRAPPAZ D
HAASE GM
HABER M
JONES DR
JOSHI VV
KANEKO M
KEMSHEAD JT
KOGNER P
LEE REJ
MATTHAY KK
MICHON JM
MONCLAIR R
ROALD BR
SEEGER RC
SHAW PJ
SHIMADA H
SHUSTER JJ
Citation: Rp. Castleberry et al., THE INTERNATIONAL NEUROBLASTOMA RISK GROUPS (INRG) - A PRELIMINARY-REPORT, European journal of cancer, 33(12), 1997, pp. 2113-2116
Authors:
PETERS J
SEEGER RC
CAI B
YAO D
HONG CM
LUKENS J
MATTHAY KK
STRAM DO
SHIMADA H
Citation: J. Peters et al., QUANTITATION OF TRK-A MESSENGER-RNA BY RT-PCR IDENTIFIES BIOLOGICALLYAND CLINICALLY DISTINCT SUBSETS OF NEUROBLASTOMA, European journal of cancer, 33(12), 1997, pp. 2139-2139
Authors:
LOH KC
FITZGERALD PA
MATTHAY KK
YEO PPB
PRICE DC
Citation: Kc. Loh et al., THE TREATMENT OF MALIGNANT METAIODOBENZYLGUANIDINE (I-131-MIBG) - A COMPREHENSIVE REVIEW OF 116 REPORTED PATIENTS, Journal of endocrinological investigation, 20(11), 1997, pp. 648-658
Authors:
KHAKOO Y
STRAM DO
MATTHAY KK
Citation: Y. Khakoo et al., NEUROLOGICAL OUTCOME IN CHILDREN WITH OPSOCLONUS-MYOCLONUS-ATAXIA SYNDROME AND NEUROBLASTOMA - A REPORT FROM THE CHILDRENS CANCER GROUP, Annals of neurology, 42(3), 1997, pp. 27-27
Authors:
ANTUNES NL
KHAKOO Y
STRAM DO
SEEGER RC
MATTHAY KK
DALMAU J
Citation: Nl. Antunes et al., ANTINEURONAL ANTIBODIES IN PATIENTS WITH NEUROBLASTOMA AND PARANEOPLASTIC OPSOCLONUS-MYOCLONUS, Annals of neurology, 42(3), 1997, pp. 128-128
Authors:
FROST JD
HANK JA
REAMAN GH
FRIERDICH S
SEEGER RC
GAN J
ANDERSON PM
ETTINGER LJ
CAIRO MS
BLAZAR BR
KRAILO MD
MATTHAY KK
REISFELD RA
SONDEL PM
Citation: Jd. Frost et al., A PHASE I IB TRIAL OF MURINE MONOCLONAL ANTI-GD2 ANTIBODY 14.G2A PLUSINTERLEUKIN-2 IN CHILDREN WITH REFRACTORY NEUROBLASTOMA - A REPORT OFTHE CHILDRENS CANCER GROUP/, Cancer, 80(2), 1997, pp. 317-333
Authors:
FRANKS LM
BOLLEN A
SEEGER RC
STRAM DO
MATTHAY KK
Citation: Lm. Franks et al., NEUROBLASTOMA IN ADULTS AND ADOLESCENTS - AN INDOLENT COURSE WITH POOR SURVIVAL, Cancer, 79(10), 1997, pp. 2028-2035
Authors:
PLANTAZ D
MOHAPATRA G
MATTHAY KK
PELLARIN M
SEEGER RC
FEUERSTEIN BG
Citation: D. Plantaz et al., GAIN OF CHROMOSOME-17 IS THE MOST FREQUENT ABNORMALITY DETECTED IN NEUROBLASTOMA BY COMPARATIVE GENOMIC HYBRIDIZATION, The American journal of pathology, 150(1), 1997, pp. 81-89
Authors:
FRANKS LM
BOLLEN A
STRAM D
MATTHAY KK
Citation: Lm. Franks et al., ADULT AND ADOLESCENT NEUROBLASTOMA - REPORT OF 15 PATIENTS AT UCSF FROM 1969-1995, Journal of investigative medicine, 44(1), 1996, pp. 137-137
Authors:
STRAM DO
MATTHAY KK
OLEARY M
REYNOLDS CP
HAASE GM
ATKINSON JB
BRODEUR GM
SEEGER RC
Citation: Do. Stram et al., CONSOLIDATION CHEMORADIOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION VERSUS CONTINUED CHEMOTHERAPY FOR METASTATIC NEUROBLASTOMA - A REPORT OF 2 CONCURRENT CHILDRENS CANCER GROUP STUDIES, Journal of clinical oncology, 14(9), 1996, pp. 2417-2426
Authors:
WILLIS B
ABLIN A
WEINBERG V
ZOGER S
WARA WM
MATTHAY KK
Citation: B. Willis et al., DISEASE COURSE AND LATE SEQUELAE OF LANGERHANS CELL HISTIOCYTOSIS - 25-YEAR EXPERIENCE AT THE UNIVERSITY-OF-CALIFORNIA, SAN-FRANCISCO, Journal of clinical oncology, 14(7), 1996, pp. 2073-2082
Authors:
DONNELLY LF
RENCKEN IO
SHARDELL K
MATTHAY KK
MILLER CR
VARTANIAN RK
GOODING CA
Citation: Lf. Donnelly et al., RENAL-CELL CARCINOMA AFTER THERAPY FOR NEUROBLASTOMA, American journal of roentgenology, 167(4), 1996, pp. 915-917
Authors:
CHOU RH
WONG GB
KRAMER JH
WARA DW
MATTHAY KK
CRITTENDEN MR
SWIFT PS
COWAN MJ
WARA WM
Citation: Rh. Chou et al., TOXICITIES OF TOTAL-BODY IRRADIATION FOR PEDIATRIC BONE-MARROW TRANSPLANTATION, International journal of radiation oncology, biology, physics, 34(4), 1996, pp. 843-851
Authors:
MATTHAY KK
Citation: Kk. Matthay, IMPACT OF MYELOABLATIVE THERAPY WITH BONE-MARROW TRANSPLANTATION IN ADVANCED NEUROBLASTOMA, Bone marrow transplantation, 18, 1996, pp. 21-24
Authors:
LANG P
VAHLENSIECK M
MATTHAY KK
JOHNSTON JO
ROSENAU W
GOODING CA
GENANT HK
Citation: P. Lang et al., MONITORING NEOVASCULARITY AS AN INDICATOR OF RESPONSE TO CHEMOTHERAPYIN OSTEOGENIC AND EWING SARCOMA USING MAGNETIC-RESONANCE ANGIOGRAPHY, Medical and pediatric oncology, 26(5), 1996, pp. 329-333
Authors:
SHIMADA H
STRAM DO
CHATTEN J
JOSHI VV
HACHITANDA Y
BRODEUR GM
LUKENS JN
MATTHAY KK
SEEGER RC
Citation: H. Shimada et al., IDENTIFICATION OF SUBSETS OF NEUROBLASTOMAS BY COMBINED HISTOPATHOLOGIC AND N-MYC ANALYSIS, Journal of the National Cancer Institute, 87(19), 1995, pp. 1470-1476
Authors:
KALRA R
ZOGER S
KOSOVICH MS
MATTHAY KK
Citation: R. Kalra et al., RADIOLOGICAL CASE-OF-THE-MONTH - MILIARY PULMONARY NEUROBLASTOMA, Archives of pediatrics & adolescent medicine, 149(2), 1995, pp. 195-196
PELVIC NEUROBLASTOMA-IMPLICATIONS FOR A NEW FAVORABLE SUBGROUP - A CHILDRENS CANCER GROUP EXPERIENCE
Authors:
HAASE GM
OLEARY MC
STRAM DO
LUKENS JN
SEEGER RC
SHIMADA H
MATTHAY KK
Citation: Gm. Haase et al., PELVIC NEUROBLASTOMA-IMPLICATIONS FOR A NEW FAVORABLE SUBGROUP - A CHILDRENS CANCER GROUP EXPERIENCE, Annals of surgical oncology, 2(6), 1995, pp. 516-523
Authors:
MATTHAY KK
OLEARY MC
RAMSAY NK
VILLABLANCA J
REYNOLDS CP
ATKINSON JB
HAASE GM
STRAM DO
SEEGER RC
Citation: Kk. Matthay et al., ROLE OF MYELOABLATIVE THERAPY IN IMPROVED OUTCOME FOR HIGH-RISK NEUROBLASTOMA - REVIEW OF RECENT CHILDRENS CANCER GROUP RESULTS, European journal of cancer, 31A(4), 1995, pp. 572-575
Authors:
VILLABLANCA JG
KHAN AA
AVRAMIS VI
SEEGER RC
MATTHAY KK
RAMSAY NKC
REYNOLDS CP
Citation: Jg. Villablanca et al., PHASE-I TRIAL OF 13-CIS-RETINOIC ACID IN CHILDREN WITH NEUROBLASTOMA FOLLOWING BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 13(4), 1995, pp. 894-901